A noninhibitory mutant of the caveolin-1 scaffolding domain enhances eNOS-derived NO synthesis and vasodilation in mice

Journal of Clinical Investigation

Volumn 121, Issue 9, 2011, Pages 3747-3755

  Bernatchez, Pascal ^a   Sharma, Arpeeta ^a   Bauer, Philip M ^b   Marin, Ethan ^b   Sessa, William C ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CAVNOXIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GENE PRODUCT; NITRIC OXIDE; PHENYLALANINE 92; PHENYLALANINE DERIVATIVE; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; BLOOD VESSEL TONE; CELL MEMBRANE PERMEABILITY; CHEMICAL ANALYSIS; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; STRUCTURE ACTIVITY RELATION; VASODILATATION;

ANIMALS; CAVEOLIN 1; CELLS, CULTURED; HUMANS; MICE; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PEPTIDES; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; VASODILATION;

EID: 80052359762     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI44778     Document Type: Article

References (27)

1. Garcia-Cardena G., Oh P., Liu J., Schnitzer J.E., Sessa W.C. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: Implications for nitric oxide signaling. Proc Natl Acad Sci U S A. 1996;93(13):6448-6453. (Pubitemid 26230326)
2. Sessa W.C., et al. The Golgi association of endothelial nitric oxide synthase is necessary for the efficient synthesis of nitric oxide. J Biol Chem. 1995; 270(30):17641-17644.
3. Parton R.G., Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol. 2007;8(3):185-194.
4. Garcia-Cardena G., et al. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. Functional significance of the nos caveolin binding domain in vivo. J Biol Chem. 1997; 272(41):25437-25440. (Pubitemid 27438846)
5. Michel J.B., Feron O., Sacks D., Michel T. Reciprocal regulation of endothelial nitric-oxide synthase by Ca2+-calmodulin and caveolin. J Biol Chem. 1997; 272(25):15583-15586. (Pubitemid 27265522)
6. Ju H., Zou R., Venema V.J., Venema R.C. Direct interaction of endothelial nitric-oxide synthase and caveolin- 1 inhibits synthase activity. J Biol Chem. 1997; 272(30):18522-18525. (Pubitemid 27318186)
7. Drab M., et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 2001;293(5539):2449-2452. (Pubitemid 32917325)
8. Razani B., et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem. 2001;276(41):38121- 38138.
9. Wunderlich C., et al. Chronic NOS inhibition prevents adverse lung remodeling and pulmonary arterial hypertension in caveolin-1 knockout mice. Pulm Pharmacol Ther. 2008;21(3):507-515. (Pubitemid 351625932)
10. Wunderlich C., et al. Nitric oxide synthases are crucially involved in the development of the severe cardiomyopathy of caveolin-1 knockout mice. Biochem Biophys Res Commun. 2008;377(3):769-774.
11. Zhao Y.Y., et al. Persistent eNOS activation secondary to caveolin-1 deficiency induces pulmonary hypertension in mice and humans through PKG nitration. J Clin Invest. 2009;119(7):2009-2018.
12. Lisanti M.P., Tang Z.L., Sargiacomo M. Caveolin forms a hetero-oligomeric protein complex that interacts with an apical GPI-linked protein: Implications for the biogenesis of caveolae. J Cell Biol. 1993;123(3):595-604. (Pubitemid 23324917)
13. Sargiacomo M., et al. Oligomeric structure of caveolin: Implications for caveolae membrane organization. Proc Natl Acad Sci U S A. 1995;92(20):9407-9411.
14. Whitsett J., Picklo M.J. Sr, Vasquez-Vivar J. 4-Hydroxy-2-nonenal increases superoxide anion radical in endothelial cells via stimulated GTP cyclohydrolase proteasomal degradation. Arterioscler Thromb Vasc Biol. 2007;27(11):2340-2347. (Pubitemid 350203948)
15. Fulton D., Gratton J.P., Sessa W.C. Post-translational control of endothelial nitric oxide synthase: Why isn't calcium/calmodulin enough? J Pharmacol Exp Ther. 2001;299(3):818-824. (Pubitemid 33104947)
16. Michel J.B., Feron O., Sase K., Prabhakar P., Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem. 1997;272(41):25907-25912. (Pubitemid 27438916)
17. Sessa W.C. eNOS at a glance. J Cell Sci. 2004; 117(pt 12):2427-2429. (Pubitemid 38877838)
18. Murata T., et al. Reexpression of caveolin-1 in endothelium rescues the vascular, cardiac, and pulmonary defects in global caveolin-1 knockout mice. J Exp Med. 2007;204(10):2373-2382. (Pubitemid 47529323)
19. Yu J., et al. Direct evidence for the role of caveolin- 1 and caveolae in mechanotransduction and remodeling of blood vessels. J Clin Invest. 2006; 116(5):1284-1291.
20. Bucci M., et al. In vivo delivery of the caveolin- 1 scaffolding domain inhibits nitric oxide synthesis and reduces inflammation. Nat Med. 2000;6(12):1362-1367. (Pubitemid 32001020)
21. Chidlow J.H. Jr, et al. Endothelial caveolin-1 regulates pathologic angiogenesis in a mouse model of colitis. Gastroenterology. 2009;136(2):575-584.
22. Gratton J.P., et al. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice. Cancer Cell. 2003; 4(1):31-39.
23. Bernatchez P.N., Bauer P.M., Yu J., Prendergast J.S., He P., Sessa W.C. Dissecting the molecular control of endothelial NO synthase by caveolin-1 using cellpermeable peptides. Proc Natl Acad Sci U S A. 2005; 102(3):761-766. (Pubitemid 40282739)
24. Bauer P.M., et al. Endothelial-specific expression of caveolin-1 impairs microvascular permeability and angiogenesis. Proc Natl Acad Sci U S A. 2005; 102(1):204-209. (Pubitemid 40094453)
25. Couet J., Li S., Okamoto T., Ikezu T., Lisanti M.P. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J Biol Chem. 1997;272(10):6525-6533. (Pubitemid 27118133)
26. Gratton J.P., Fontana J., O'Connor D.S., Garcia- Cardena G, McCabe TJ, Sessa WC. Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J Biol Chem. 2000;275(29):22268-22272. (Pubitemid 30621809)
27. Dikalov S., Griendling K.K., Harrison D.G. Measurement of reactive oxygen species in cardiovascular studies. Hypertension. 2007;49(4):717-727. (Pubitemid 351688335)